Novavax gets $1.6 billion in federal funding for Covid-19 vaccine development

The U.S. government has awarded Novavax $1.6 billion to support the late-stage development and scale up in manufacturing of its Covid-19 vaccine. CNBC's Meg Tirrell reports.